Skip to main content
. 2017 Oct 20;14(6):8156–8161. doi: 10.3892/ol.2017.7234

Figure 1.

Figure 1.

cAMP response element-binding protein 5 (CREB5) is negatively associated with ovarian cancer prognosis. (A) CREB5 expression profiling from GSE41 2 datasets (n=46). (B) Overall survival of patients with low vs. high CREB5 expression in the GSE4122 dataset (n=580). (C) Relapse-free survival of patients with low vs. high CREB5 expression in the GSE4122 dataset (n=484).